Mineralys Therapeutics, Inc. · 4 weeks ago
Senior Manager, Medical Communications - Medical Affairs
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines for hypertension and related comorbidities. They are seeking a Senior Manager in Medical Communications to oversee the development and dissemination of medical education content to support clinical research initiatives, ensuring accuracy and relevance for both internal and external stakeholders.
BiopharmaBiotechnologyMedicalPharmaceutical
Responsibilities
Deliver high-quality, impactful scientific content that support both internal stakeholders (e.g., Field Medical) and external stakeholders (e.g., healthcare professionals)
Assist with development, review and/or maintenance of product and disease-related slide kits, symposia, digital education
Leverage digital (SERMO, podcasts, videos), omnichannel tools, and AI-driven solutions to innovate and enhance Medical Communication strategies, ensuring impactful and data-driven engagement with healthcare professionals and stakeholders
Contribute to medical congress activities, as needed, including support for booth content, scientific content and session coverage; create post-congress summary materials
Own the development, pull-through and execution of the Scientific Narrative and Scientific Communication Platform (SCP)
Participate in the creation and execution of scientific content plan for the fiscal year, including alignment with the Medical Plan
Develop program specific scientific materials such as mechanism of disease or action graphics, data summary decks, and templates for company wide use
Manage external vendors and agencies to deliver high-quality live and virtual medical education programs
Monitor and assess the effectiveness of medical education initiatives and provide feedback to cross functional teams for continuous improvement
Align with cross-functional teams to develop a dynamic and evolving Independent Medical Education program
Qualification
Required
Must have an advanced medical degree (MD, DO, or equivalent), PharmD or PhD
3+ years of medical affairs experience in the Pharmaceutical/Biotechnology industry
Exceptional communication, negotiation, and stakeholder management skills
Ability to lead/manage multiple projects and priorities in a fast-paced, matrixed environment
Champion unwavering commitment to scientific rigor and data-driven decision-making
Able to ascertain scientific accuracy, stakeholder relevance, and appropriateness of the various formats utilized across all the scientific content materials
Must have strong business acumen, ability to interface with matrix partners to make trade-off decisions by managing Medical Communications Asset/Indication-level budget and allocation of funds and resources to highest business priorities
Able to manage budgets and vendors
Willingness to take on ad hoc work or special projects as needed
This position requires up to 10% travel. Frequently travel is outside the local area and overnight. Some of the travel may be international
Demonstrated understanding of laws, regulations, standards, and guidance governing the conduct of publications
Strong understanding of compliance and regulatory frameworks governing scientific exchange
Strong understanding of regulatory requirements (e.g., FDA, EMA) and industry standards (e.g., GPP, ICH, PhRMA Code)
Preferred
Experience in hypertension, sleep apnea, chronic kidney disease, launch experience preferred
Experience in budget and vendor management
Proven success in a fast-paced, entrepreneurial, smaller company environment is highly desired
Proven experience in working collaboratively and cross functionally across field medical teams, corporate affairs, clinical development, commercial, sales, market access and other key functions and demonstrated ability to inform and shape company/product strategy
Proven experience collaborating with cross-functional, international teams
Benefits
Medical
Dental
Vision
Time off
401K
Company
Mineralys Therapeutics, Inc.
At Mineralys Therapeutics we aim to redefine hypertension diagnosis, management and treatment.
Funding
Current Stage
Public CompanyTotal Funding
$740.5MKey Investors
TCG Crossover
2025-09-02Post Ipo Equity· $287.5M
2025-03-11Post Ipo Equity· $175M
2024-02-08Post Ipo Equity· $120M
Leadership Team
Recent News
Company data provided by crunchbase